Important Anti-Cancer Applications of Protein Based Nanoparticles

ISSN: 1875-6247 (Online)
ISSN: 1570-1646 (Print)

Volume 14, 4 Issues, 2017

Download PDF Flyer

Current Proteomics

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Bernd Rehm
Institute of Molecular BioSciences Massey University
Private Bag 11222
Palmerston North
New Zealand

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 0.59
5 - Year: 0.606

Important Anti-Cancer Applications of Protein Based Nanoparticles

Current Proteomics, 10(4): 334-340.

Author(s): Mustafa Ergul, Merve Ergul and Yusuf Tutar.

Affiliation: Division of Biochemistry, Cumhuriyet University, 58140, Sivas, Turkey.


Cancer is one of the most important health problems in the world and the treatment approaches are still challenging and generally not at desirable levels. Conventional anti-cancer agents may cause systemic toxicity, have poor solubility, and lack of selectivity. In order to overcome these hurdles, nanoparticle based therapeutics have been widely employed to enhance therapeutic efficacies and reduce systemic toxicity of pharmaceutical agents. In recent years, nanoparticulate carrier systems (NPCs) in medicine have attracted considerable scientific attention and interest in the worldwide because of their unique properties in the diagnosis and therapy of many diseases including cancer. One of the therapeutic strategies of NPCs is protein based nanoparticles. Human serum albumin (HSA) and bovine serum albumin (BSA) are the most frequently used materials for this purpose due to their remarkable advantages. In this review article, we focused on protein based nanoparticles and summarized their important applications including anti-cancer drug delivery, photodynamic therapy, and gene delivery.


Anti-cancer drug delivery, bovine serum albumin, gene delivery, human serum albumin, photodynamic therapy, protein based nanoparticles.

Download Free Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 10
Issue Number: 4
First Page: 334
Last Page: 340
Page Count: 7
DOI: 10.2174/15701646113106660006

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science